These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 19648167

  • 21. Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.
    Morris E, Thomson K, Craddock C, Mahendra P, Milligan D, Cook G, Smith GM, Parker A, Schey S, Chopra R, Hatton C, Tighe J, Hunter A, Peggs K, Linch D, Goldstone A, Mackinnon S.
    Blood; 2004 Dec 15; 104(13):3865-71. PubMed ID: 15304395
    [Abstract] [Full Text] [Related]

  • 22. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission.
    Pidala J, Djulbegovic B, Anasetti C, Kharfan-Dabaja M, Kumar A.
    Cochrane Database Syst Rev; 2011 Oct 05; 2011(10):CD008818. PubMed ID: 21975786
    [Abstract] [Full Text] [Related]

  • 23. Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Onishi Y, Sasaki O, Ichikawa S, Inokura K, Katsuoka Y, Ohtsuka Ohba R, Okitsu Y, Kohata K, Ohguchi H, Fukuhara N, Yokoyama H, Yamada MF, Yamamoto J, Ishizawa K, Kameoka J, Harigae H.
    Biol Blood Marrow Transplant; 2011 Jul 05; 17(7):1093-7. PubMed ID: 21277378
    [Abstract] [Full Text] [Related]

  • 24. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2008 Jun 05; 93(6):834-41. PubMed ID: 18469352
    [Abstract] [Full Text] [Related]

  • 25. BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.
    Faulkner RD, Craddock C, Byrne JL, Mahendra P, Haynes AP, Prentice HG, Potter M, Pagliuca A, Ho A, Devereux S, McQuaker G, Mufti G, Yin JL, Russell NH.
    Blood; 2004 Jan 15; 103(2):428-34. PubMed ID: 12969983
    [Abstract] [Full Text] [Related]

  • 26. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
    Tomblyn MB, Arora M, Baker KS, Blazar BR, Brunstein CG, Burns LJ, DeFor TE, Dusenbery KE, Kaufman DS, Kersey JH, MacMillan ML, McGlave PB, Miller JS, Orchard PJ, Slungaard A, Tomblyn MR, Vercellotti GM, Verneris MR, Wagner JE, Weisdorf DJ.
    J Clin Oncol; 2009 Aug 01; 27(22):3634-41. PubMed ID: 19581540
    [Abstract] [Full Text] [Related]

  • 27. Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab.
    Das-Gupta EP, Russell NH, Shaw BE, Pearce RM, Byrne JL.
    Biol Blood Marrow Transplant; 2007 Jun 01; 13(6):724-33. PubMed ID: 17531783
    [Abstract] [Full Text] [Related]

  • 28. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
    Chen J, Wu DP, Chen F, Zhao Y, Sun AN, Qiu HY.
    Zhonghua Yi Xue Za Zhi; 2013 Feb 26; 93(8):583-7. PubMed ID: 23663336
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
    Ferrá C, Sanz J, de la Cámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM, GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology.
    Biol Blood Marrow Transplant; 2010 Jul 26; 16(7):957-66. PubMed ID: 20144909
    [Abstract] [Full Text] [Related]

  • 32. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Huang XJ.
    Biol Blood Marrow Transplant; 2015 Jun 26; 21(6):1110-6. PubMed ID: 25698612
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
    van Besien K, Artz A, Smith S, Cao D, Rich S, Godley L, Jones D, Del Cerro P, Bennett D, Casey B, Odenike O, Thirman M, Daugherty C, Wickrema A, Zimmerman T, Larson RA, Stock W.
    J Clin Oncol; 2005 Aug 20; 23(24):5728-38. PubMed ID: 16009946
    [Abstract] [Full Text] [Related]

  • 35. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Wang J, Jiang Q, Xu LP, Zhang XH, Chen H, Qin YZ, Ruan GR, Jiang H, Jia JS, Zhao T, Liu KY, Jiang B, Huang XJ.
    Biol Blood Marrow Transplant; 2018 Apr 20; 24(4):741-750. PubMed ID: 29247779
    [Abstract] [Full Text] [Related]

  • 36. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M, Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG), Tokyo, Japan.
    Jpn J Clin Oncol; 2012 May 20; 42(5):394-404. PubMed ID: 22422899
    [Abstract] [Full Text] [Related]

  • 37. In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation.
    Kanda Y, Oshima K, Asano-Mori Y, Kandabashi K, Nakagawa M, Sakata-Yanagimoto M, Izutsu K, Hangaishi A, Tsujino S, Ogawa S, Motokura T, Chiba S, Hirai H.
    Transplantation; 2005 May 27; 79(10):1351-7. PubMed ID: 15912103
    [Abstract] [Full Text] [Related]

  • 38. A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia.
    Piemontese S, Ciceri F, Labopin M, Bacigalupo A, Huang H, Santarone S, Gorin NC, Koc Y, Wu D, Beelen D, Tischer J, Ehninger G, Arcese W, Nagler A, Mohty M, Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT).
    Leukemia; 2015 May 27; 29(5):1069-75. PubMed ID: 25434302
    [Abstract] [Full Text] [Related]

  • 39. Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission.
    Eom KS, Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Kim YJ, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Park CW, Lee S.
    Am J Hematol; 2013 Aug 27; 88(8):634-41. PubMed ID: 23620000
    [Abstract] [Full Text] [Related]

  • 40. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
    Kebriaei P, Saliba R, Rondon G, Chiattone A, Luthra R, Anderlini P, Andersson B, Shpall E, Popat U, Jones R, Worth L, Ravandi F, Thomas D, O'Brien S, Kantarjian H, de Lima M, Giralt S, Champlin R.
    Biol Blood Marrow Transplant; 2012 Apr 27; 18(4):584-92. PubMed ID: 21867666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.